ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

NEPH Nephros Inc

2.07
-0.02 (-0.96%)
26 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Nephros Inc NEPH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.02 -0.96% 2.07 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.09 2.07 2.123 2.07 2.09
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/6/202416:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
24/5/202415:05EDGAR2Form 8-K - Current report
23/5/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
16/5/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:16EDGAR2Form S-3 - Registration statement under Securities Act of..
09/5/202415:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/3/202415:15GLOBENephros Announces Fourth Quarter and Fiscal Year 2023..
29/2/202415:30GLOBENephros Schedules Conference Call for Fourth Quarter and..
15/12/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202315:15GLOBENephros Announces Results for Quarter Ended September 30,..
08/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202315:05EDGAR2Form 8-K - Current report
03/11/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202306:30GLOBENephros Hires Judy Krandel as Chief Financial Officer
25/10/202306:30GLOBENephros Schedules Third Quarter 2023 Financial Results..
15/8/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:15EDGAR2Form 8-K - Current report
09/8/202315:15GLOBENephros Announces Results for Quarter Ended June 30, 2023
09/8/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/7/202306:30GLOBENephros Schedules Second Quarter 2023 Financial Results..